-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BsJg82KP/WeNkBAiHo/CrMSKjsN56Z4Qv1Tq4IudjZ7WdgQFlYB+OXBt1l8Bu1Pi +RMgu47yStDJ52ZW+xbfGw== 0000950116-04-003822.txt : 20041217 0000950116-04-003822.hdr.sgml : 20041217 20041217172207 ACCESSION NUMBER: 0000950116-04-003822 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20041217 DATE AS OF CHANGE: 20041217 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Hana Biosciences Inc CENTRAL INDEX KEY: 0001140028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841588441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-79910 FILM NUMBER: 041212171 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BOULEVARD STREET 2: SUITE 215 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6505886404 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BOULEVARD STREET 2: SUITE 215 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EMAIL REAL ESTATE COM INC DATE OF NAME CHANGE: 20010504 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Lipschutz Lester E CENTRAL INDEX KEY: 0001308379 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: BUSINESS PHONE: 215 977 2046 MAIL ADDRESS: STREET 1: WOLF BLOCK SCHORR AND SOLIS COHEN STREET 2: 1650 ARCH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: Lipshutz Lester E DATE OF NAME CHANGE: 20041110 SC 13G 1 sc13-g.txt SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________ SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 Hana Biosciences, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $.001 per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 268749108 - -------------------------------------------------------------------------------- (CUSIP NUMBER) December 15, 2004 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: / / Rule 13d-1(b) /X/ Rule 13d-1(c) / / Rule 13d-1(d) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 Pages SCHEDULE 13G ========================= ========================= CUSIP No. 268749108 Page 2 of 5 Pages ========================= ========================= ________________________________________________________________________________ | 1. | NAME OF REPORTING PERSONS: LESTER E. LIPSCHUTZ | I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) ___|____________________________________________________________________________ | 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | | (a) [ ] | (b) [ ] ___|____________________________________________________________________________ | 3. | SEC USE ONLY ___|____________________________________________________________________________ | 4. | CITIZENSHIP or PLACE OF ORGANIZATION United States ___|____________________________________________________________________________ | | NUMBER OF |5. | SOLE VOTING POWER 2,063,662 SHARES |____|____________________________________________________________ BENEFICIALLY | | OWNED BY |6. | SHARED VOTING POWER 0 EACH |____|____________________________________________________________ REPORTING | | PERSON WITH |7. | SOLE DISPOSITIVE POWER 2,063,662 |____|____________________________________________________________ | | |8. | SHARED DISPOSITIVE POWER 0 ______________|____|____________________________________________________________ 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,063,662 ___|____________________________________________________________________________ 10.| CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES | CERTAIN SHARES: [ ] ___|____________________________________________________________________________ 11.| PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 19.11(1) ___|____________________________________________________________________________ 12 | TYPE OF REPORTING PERSON IN ___|____________________________________________________________________________ SCHEDULE 13G ========================= ========================= CUSIP No. 268749108 Page 3 of 5 Pages ========================= ========================= Item 1(a). Name of Issuer: Hana Biosciences, Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 400 Oyster Point Blvd. Suite 215 South San Francisco, CA 94080 Item 2(a). Name of Person Filing: Lester E. Lipschutz Item 2(b). Address of Principal Business Office or, if None, Residence: Wolf, Block, Schorr and Solis-Cohen, LLP 1650 Arch Street- 22nd Floor Philadelphia, PA 19103 Item 2(c). Citizenship: United States Item 2(d). Title of Class of Securities: Common Stock Item 2(e). CUSIP Number: 268749108 Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: Not Applicable (a) [ ] Broker or dealer registered under Section 15 of the Exchange Act; (b) [ ] Bank as defined in Section 3(a)(6) of the Exchange Act; (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Exchange Act; (d) [ ] Investment Company registered under Section 8 of the Investment Company Exchange Act; SCHEDULE 13G ========================= ========================= CUSIP No. 268749108 Page 4 of 5 Pages ========================= ========================= (e) [ ] Investment Adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [ ] Employee Benefit Plan or Endowment Fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [ ] Parent Holding Company or Control Person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [ ] Saving Association as defined in Section 3(b) of The Federal Deposit Insurance Act; (i) [ ] Church Plan that is excluded from the definition of an Investment Company under Section 3(c)(14) of the Investment Company Act; (j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). Item 4. Ownership. (a) Amount beneficially owned: Mr. Lipschutz may be deemed the beneficial owner of 2,063,662. Beneficial ownership consists of voting and dispositive power over (i) 172,083 shares owned by the Lindsay A. Rosenwald Alaska Irrevocable Indenture of Trust for which Mr. Lipschutz is trustee; (ii) 172,083 shares owned by the Lindsay A. Rosenwald Rhode Island Irrevocable Indenture of Trust for which Mr. Lipschutz serves as the adviser; (iii) 172,083 shares owned by the Lindsay A. Rosenwald 2000 (Delaware) Irrevocable Indenture of Trust for which Mr. Lipschutz serves as the adviser; (iv) 172,083 shares owned by the Lindsay A. Rosenwald Nevada Irrevocable Indenture of Trust for which Mr. Lipschutz is trustee; and (v) 1,375,330 shares owned by the Rosenwald 2000 Family Trusts for which Mr. Lipschutz is the trustee (none of which trusts own individually more than 5% of the issuer's securities). Mr. Lipschutz disclaims beneficial ownership of these securities and the filing of this report is not an admission that Mr. Lipschutz us the beneficial owner of these securities. (b) Percent of Class: 19.11%(1) (c) Number of shares as to which such person has: (i) Sole power to vote or direct the vote: 2,063,662 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or direct the disposition of: 2,063,662 (iv) Shared power to dispose or to direct the disposition of: 0 SCHEDULE 13G ========================= ========================= CUSIP No. 268749108 Page 5 of 5 Pages ========================= ========================= Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [] Item 6. Ownership of More than Five Percent on Behalf of Another Person. As of December 15, 2004, Mr. Lipschutz serves as (i) trustee of the Lindsay A. Rosenwald Alaska Irrevocable Indenture of Trust; (ii) adviser of the Lindsay A. Rosenwald Rhode Island Irrevocable Indenture of Trust; (iii) adviser of the Lindsay A. Rosenwald 2000 (Delaware) Irrevocable Indenture of Trust; (iv) trustee of the Lindsay A. Rosenwald Nevada Irrevocable Indenture of Trust; and (v) trustee of the Rosenwald 2000 Family Trusts. Mr. Lipschutz has the power to direct receipt of the proceeds from a sale of the shares owned by each such trust. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. December 16, 2004 -------------------------- (Date) Lester E. Lipschutz -------------------------- (Signature) Lester E. Lipschutz -------------------------- (Name/Title) (1) Based on 10,796,980 shares reported outstanding at November 9, 2004. -----END PRIVACY-ENHANCED MESSAGE-----